Correction: MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells

Guodong Xiao; Xiang Li; Gang Li; Boxiang Zhang; Chongwen Xu; Sida Qin; Ning Du; Jichang Wang; Shou-Ching Tang; Jing Zhang; Hong Ren; Ke Chen; Xin Sun

doi:10.18632/oncotarget.28201

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells

PDF | How to cite

Oncotarget. 2023; 14:809-809. https://doi.org/10.18632/oncotarget.28201

Metrics: PDF 410 views | ?

Guodong Xiao^1,*, Xiang Li^1,*, Gang Li^1,*, Boxiang Zhang¹, Chongwen Xu², Sida Qin¹, Ning Du¹, Jichang Wang³, Shou-Ching Tang^4,5, Jing Zhang¹, Hong Ren¹, Ke Chen⁶ and Xin Sun¹

¹Department of Thoracic Surgery and Oncology, The Second Department of Thoracic Surgery, Cancer Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
²Department of Otorhinolaryngology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
³Department of Vascular and Endovascular Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
⁴Breast Cancer Program and Interdisciplinary Translational Research Team, Georgia Regents University Cancer Center, Augusta, Georgia 30912, United States
⁵Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
⁶Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
^*These authors are considered as co-first authors

Published: September 15, 2023

Copyright: © 2023 Xiao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: In Figure 3D, the MCF-7 ‘Control’ image is an accidental duplicate of the ZR75-1 ‘Control’ image. The corrected Figure 3, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:103261–103273. DOI: https://doi.org/10.18632/oncotarget.21143

Figure 3: Suppressive miR-129 functions through inhibition on ESR1 and NOTCH signaling in breast cancer stem cells. (D) Enforced miR-129 expression decreased the proportion of CD44+/24− cells significantly, however NUMB inhibition induced NOTCH activation abolished the suppressive functions of miR-129.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28201

Publication Alerts

Corrections:

Correction: MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells